RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 41 filers reported holding RAIN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $14,405,399 | -27.5% | 1,648,215 | -33.6% | 0.42% | -23.8% |
| Q4 2022 | $19,868,952 | +63.9% | 2,483,619 | 0.0% | 0.56% | +58.5% |
| Q3 2022 | $12,120,000 | -12.2% | 2,483,619 | 0.0% | 0.35% | -18.7% |
| Q2 2022 | $13,809,000 | +9.7% | 2,483,619 | 0.0% | 0.43% | +71.8% |
| Q1 2022 | $12,592,000 | -80.3% | 2,483,619 | -50.0% | 0.25% | -48.9% |
| Q4 2021 | $63,978,000 | +68.6% | 4,967,238 | +95.8% | 0.49% | -10.5% |
| Q3 2021 | $37,954,000 | -51.9% | 2,537,019 | -50.0% | 0.55% | +7.6% |
| Q2 2021 | $78,850,000 | – | 5,074,038 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,637,308 | $25,444,000 | 3.14% |
| Cormorant Asset Management, LP | 2,626,660 | $39,734,000 | 1.35% |
| BVF INC/IL | 1,945,949 | $30,240,000 | 1.13% |
| Logos Global Management LP | 780,331 | $12,126,000 | 1.02% |
| ACUTA CAPITAL PARTNERS, LLC | 162,245 | $2,521,000 | 1.01% |
| LUMINUS MANAGEMENT LLC | 425,000 | $6,605,000 | 0.96% |
| Boxer Capital, LLC | 1,175,000 | $18,260,000 | 0.64% |
| Perceptive Advisors | 5,074,038 | $78,850,000 | 0.51% |
| Lumina Fund Management LLC | 6,000 | $93,000 | 0.04% |
| Monashee Investment Management LLC | 20,000 | $311,000 | 0.04% |